Exclusive: Vaccine maker Serum waives AstraZeneca shot indemnity for refugee programme By Reuters

Exclusive: Vaccine maker Serum waives AstraZeneca shot indemnity for refugee programme By Reuters
Exclusive: Vaccine maker Serum waives AstraZeneca shot indemnity for refugee programme© Reuters. FILE PHOTO: An employee in personal protective equipment (PPE) removes vials of AstraZeneca’s COVISHIELD, coronavirus disease (COVID-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India, Pune, India, November 30, 2020. REU

By Francesco Guarascio and Pushkala Aripaka

(Reuters) – The Serum Institute of India (SII) has waived its protection from legal liabilities for any AstraZeneca-Oxford COVID-19 shots it supplies to a global programme for refugees, a spokesperson for the GAVI vaccine alliance told Reuters on Wednesday.

The news comes days after Reuters reported that tens of millions of migrants may be denied COVID-19 vaccines from the vaccine-sharing programme COVAX because of concerns over who would be liable in the event of harmful side-effects.

Many COVID-19 vaccine manufacturers require that countries indemnify them for any adverse events…

Continue reading

Leave a Reply

Your email address will not be published. Required fields are marked *